Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004195
What this trial is testing

Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)UnknownNCT02870153
What this trial is testing

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
The First People's Hospital of Changzhou 60
Not applicableNot Yet RecruitingNCT07685236
What this trial is testing

A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)

Who this might be right for
Metastatic Colorectal Cancer (CRC)
The First Affiliated Hospital with Nanjing Medical University 586
Large-scale testing (Phase 3)Looking for participantsNCT07228832
What this trial is testing

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Summit Therapeutics 600
Not applicableStudy completedNCT06903039
What this trial is testing

NeoRes Study - Preoperative Chemotherapy in Colorectal Peritoneal Disease Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Colorectal Cancer MetastaticPeritoneal Metastases From Colorectal Cancer
Uppsala University 185
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Large-scale testing (Phase 3)Study completedNCT04737187
What this trial is testing

Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients

Who this might be right for
Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc. 492
Testing effectiveness (Phase 2)Study completedNCT01358812
What this trial is testing

FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colo-rectal Cancer
Gruppo Oncologico del Nord-Ovest 37
Testing effectiveness (Phase 2)Study completedNCT01181609
What this trial is testing

Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 54
Testing effectiveness (Phase 2)Ended earlyNCT05397171
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Who this might be right for
Urinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung
AstraZeneca 17
Testing effectiveness (Phase 2)Study completedNCT02414009
What this trial is testing

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 82
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT04534218
What this trial is testing

Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer

Who this might be right for
Colo-rectal CancerMetastatic Cancer
Centre Hospitalier Universitaire de Besancon 49
Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Testing effectiveness (Phase 2)UnknownNCT05551247
What this trial is testing

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 30
Large-scale testing (Phase 3)Study completedNCT00004252
What this trial is testing

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Pfizer
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714447
What this trial is testing

Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer

Who this might be right for
CRC (Colorectal Cancer)BRAF
Sun Yat-sen University 91
Early research (Phase 1)Active Not RecruitingNCT02817633
What this trial is testing

TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Who this might be right for
Neoplasms
Tesaro, Inc. 463
Testing effectiveness (Phase 2)Study completedNCT01281761
What this trial is testing

Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)

Who this might be right for
Metastatic Colorectal Cancer
Samsung Medical Center 52
Not applicableStudy completedNCT01959269
What this trial is testing

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy

Who this might be right for
Colorectal Neoplasm
Bayer 483
Next Page